Infection with congenital cytomegalovirus remains the leading non-genetic cause of sensorineural hearing loss and neurodevelopmental disability worldwide. While many infected neonates remain asymptomatic, those with symptomatic presentation face substantial risks of central nervous system involvement. Clinicians have long sought reliable biomarkers to anticipate severe neurological sequelae such as intractable seizures. Consequently, recent clinical evidence has highlighted neonatal neuroimaging as an indispensable tool for prognostic stratification. In particular, early cranial magnetic resonance imaging provides critical insights into structural brain disruptions caused by viral teratogenesis. Identifying these structural anomalies during early infancy allows healthcare teams to design tailored surveillance strategies. Therefore, recognizing specific radiological patterns helps clinicians identify high-risk infants before seizures manifest clinically.

Predictive Value of Neonatal Neuroimaging in Congenital Cytomegalovirus

Cranial magnetic resonance imaging during the neonatal period offers unprecedented anatomical detail regarding viral-induced brain damage. In a dedicated retrospective cohort study of infants with congenital cytomegalovirus, researchers evaluated neuroimaging before four months of age. The investigators utilized validated scoring systems to correlate structural parenchymal lesions with long-term neurological outcomes. Notably, the study revealed that nearly ten percent of symptomatic infants developed clinical epilepsy during early childhood. Conversely, none of the asymptomatic neonates in the cohort developed seizure disorders during follow-up. Furthermore, infants who subsequently experienced seizures exhibited significantly higher rates of major structural abnormalities on baseline scans. Quantitative scoring systems successfully differentiated mild transient changes from severe progressive cortical malformations. Hence, early neuroimaging serves as an essential prognostic baseline rather than a simple diagnostic confirmation.

Polymicrogyria as a Key Marker of Epileptogenesis

Among the spectrum of brain abnormalities, polymicrogyria emerged as the most decisive predictor of secondary epilepsy. Polymicrogyria represents a malformation of cortical development characterized by excessive small gyri and abnormal cortical lamination. Cytomegalovirus exhibits a specific tropism for neural progenitor cells and radial glia during early gestation. As a result, viral replication disrupts normal neuronal migration and cortical organization within the developing fetal cerebrum. The cohort data demonstrated that cortical malformations, particularly polymicrogyria, occurred in eighty-six percent of infants who developed epilepsy. In contrast, infants without epilepsy demonstrated these severe malformations in only fifteen percent of cases. Additionally, white matter changes and ventriculomegaly occurred frequently across both groups but lacked specific predictive power for epileptogenesis. Therefore, identifying polymicrogyria should alert clinicians to a profoundly elevated risk of subsequent seizure activity.

Clinical Presentation and Risk Stratification in Symptomatic Neonates

Clinical presentation at birth plays a foundational role in assessing overall neurological vulnerability. Symptomatic congenital cytomegalovirus frequently presents with microcephaly, petechial rash, hepatosplenomegaly, thrombocytopenia, and intrauterine growth restriction. The presence of these systemic manifestations correlates strongly with the severity of intracranial pathology. In the cohort analysis, all infants who ultimately developed epilepsy were symptomatic at birth. However, systemic symptoms alone cannot reliably differentiate which symptomatic infants will develop recurrent seizures. Instead, combining clinical markers with comprehensive magnetic resonance imaging provides optimal prognostic discrimination. For instance, an infant with microcephaly and extensive polymicrogyria requires a vastly different monitoring pathway than an infant with isolated mild thrombocytopenia. Consequently, risk stratification protocols must integrate clinical examination, laboratory findings, and specialized neuroimaging assessments.

Management Strategies and Long-Term Neurological Surveillance

Proactive management of high-risk infants necessitates multidisciplinary coordination and anticipatory clinical guidance. When imaging confirms polymicrogyria, clinicians should establish structured neurodevelopmental surveillance pathways immediately. Furthermore, educating parents regarding subtle seizure semiology, including infantile spasms and focal motor seizures, facilitates early parental recognition. Clinicians frequently initiate antiviral therapy with oral valganciclovir or intravenous ganciclovir during the neonatal window to mitigate hearing loss and developmental decline. Although antiviral therapy halts ongoing viral replication, it cannot reverse established structural dysplasias such as polymicrogyria. Therefore, paediatric neurologists must maintain regular electroencephalographic monitoring in children showing suspicious developmental stalls. Early electroencephalography allows prompt detection of hypsarrhythmia or focal epileptiform discharges, enabling rapid antiepileptic drug initiation.

Translating MRI Findings into Clinical Practice in Resource-Limited Settings

Implementing advanced neuroimaging protocols presents unique challenges in low- and middle-income healthcare environments. High-field magnetic resonance imaging may not be universally available in every regional neonatal center. In such circumstances, skilled cranial ultrasonography can detect ventriculomegaly, periventricular calcifications, and lenticulostriate vasculopathy. Nevertheless, clinicians must recognize that cranial ultrasound frequently fails to identify subtle polymicrogyria and migratory cortical defects. Therefore, tertiary referral centers should prioritize magnetic resonance imaging for all infants born with symptomatic congenital cytomegalovirus. Establishing standardized imaging protocols and telemedicine consultations with pediatric neuroradiologists can bridge regional diagnostic gaps. Ultimately, precise early diagnosis optimizes resource allocation and ensures timely intervention for vulnerable pediatric populations.

Frequently Asked Questions

What makes polymicrogyria a strong predictor of epilepsy?

Polymicrogyria disrupts normal cerebral cortical lamination and neural circuitry. This abnormal structural architecture creates highly hyperexcitable neuronal networks prone to generating spontaneous epileptiform discharges. Consequently, infants with viral-induced cortical dysplasia face a substantially higher risk of developing pharmacoresistant focal seizures or infantile spasms during early development.

Can antiviral treatment prevent epilepsy in infants with cortical malformations?

Antiviral therapies such as valganciclovir suppress active viral replication and may improve hearing outcomes and neurodevelopment. However, antivirals cannot repair preexisting structural malformations like polymicrogyria that develop during early fetal gestation. Clinicians must therefore maintain vigilant seizure monitoring regardless of antiviral treatment completion.

When should an infant with congenital cytomegalovirus undergo neuroimaging?

Clinicians should perform magnetic resonance imaging within the first month of life, ideally before four months of age. Early imaging provides clear visualization of myelination patterns, calcifications, and cortical organization, establishing an essential anatomical baseline for predicting long-term neurological risks and planning personalized therapeutic interventions.

Disclaimer: This content is for informational and educational purposes only and is not intended to serve as medical advice, diagnosis, or treatment. Medical knowledge is constantly evolving; clinicians must exercise their independent clinical judgment when evaluating research and applying it to individual patient care. Refer to the latest local and national guidelines for clinical practice.

References

1. Lawson G et al. Polymicrogyria in infants with symptomatic congenital cytomegalovirus at birth is associated with epilepsy: A retrospective, descriptive cohort study. Dev Med Child Neurol. 2025 Aug. doi: 10.1111/dmcn.16250. PMID: 39869483.
2. Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations on prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188.
3. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012;135(Pt 5):1348-1369.
4. Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43(1):38.